California State Teachers Retirement System (CalSTRS)’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.68M | Buy |
332,187
+102,020
| +44% | +$516K | ﹤0.01% | 1456 |
|
|
2025
Q1 | $1.22M | Sell |
230,167
-1,368
| -0.6% | -$7.24K | ﹤0.01% | 1594 |
|
|
2024
Q4 | $1.57M | Buy |
231,535
+54,449
| +31% | +$368K | ﹤0.01% | 1522 |
|
|
2024
Q3 | $1.17M | Buy |
177,086
+8,064
| +5% | +$53.1K | ﹤0.01% | 1697 |
|
|
2024
Q2 | $1.27M | Buy |
169,022
+14,531
| +9% | +$109K | ﹤0.01% | 1637 |
|
|
2024
Q1 | $1.54M | Buy |
154,491
+4,828
| +3% | +$48.1K | ﹤0.01% | 1563 |
|
|
2023
Q4 | $1.48M | Buy |
149,663
+5,333
| +4% | +$52.6K | ﹤0.01% | 1623 |
|
|
2023
Q3 | $1.1M | Sell |
144,330
-14,062
| -9% | -$108K | ﹤0.01% | 1731 |
|
|
2023
Q2 | $1.18M | Buy |
158,392
+59,698
| +60% | +$446K | ﹤0.01% | 1811 |
|
|
2023
Q1 | $658K | Buy |
98,694
+1,102
| +1% | +$7.35K | ﹤0.01% | 2152 |
|
|
2022
Q4 | $752K | Buy |
97,592
+1,326
| +1% | +$10.2K | ﹤0.01% | 2097 |
|
|
2022
Q3 | $1.02M | Sell |
96,266
-2,254
| -2% | -$24K | ﹤0.01% | 1873 |
|
|
2022
Q2 | $802K | Buy |
98,520
+14,123
| +17% | +$115K | ﹤0.01% | 2106 |
|
|
2022
Q1 | $604K | Sell |
84,397
-11,938
| -12% | -$85.4K | ﹤0.01% | 2317 |
|
|
2021
Q4 | $1.65M | Buy |
96,335
+81,132
| +534% | +$1.39M | ﹤0.01% | 1852 |
|
|
2021
Q3 | $350K | Sell |
15,203
-13,951
| -48% | -$321K | ﹤0.01% | 2562 |
|
|
2021
Q2 | $1.06M | Buy |
+29,154
| New | +$1.06M | ﹤0.01% | 2175 |
|